Other Current Liabilities - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Other Current Liabilities Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Other Current Liabilities
€462k
CAGR 3-Years
-51%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Other Current Liabilities
€29.9m
CAGR 3-Years
-56%
CAGR 5-Years
19%
CAGR 10-Years
21%
Nanobiotix SA
PAR:NANO
Other Current Liabilities
€37.9m
CAGR 3-Years
67%
CAGR 5-Years
54%
CAGR 10-Years
44%
Innate Pharma SA
PAR:IPH
Other Current Liabilities
€3.2m
CAGR 3-Years
-42%
CAGR 5-Years
-41%
CAGR 10-Years
12%
Genfit SA
NASDAQ:GNFT
Other Current Liabilities
€15.9m
CAGR 3-Years
103%
CAGR 5-Years
100%
CAGR 10-Years
17%
Eurobio Scientific SA
PAR:ALERS
Other Current Liabilities
€18.7m
CAGR 3-Years
-2%
CAGR 5-Years
24%
CAGR 10-Years
23%

See Also

What is Gensight Biologics SA's Other Current Liabilities?
Other Current Liabilities
462k EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Other Current Liabilities amounts to 462k EUR.

What is Gensight Biologics SA's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
39%

Over the last year, the Other Current Liabilities growth was -39%. The average annual Other Current Liabilities growth rates for Gensight Biologics SA have been -51% over the past three years , 39% over the past five years .

Back to Top